BioSpace News Archive

Equillium, Inc. today announced that abstracts were accepted for poster presentations at the annual meetings of the American Society of Nephrology (ASN) and the American College of Rheumatology (ACR).

Avinger, Inc. today announced that it will release its financial results for the third quarter 2023 after the close of trading on Thursday, October 26, 2023.

Immunome , Inc. today announced the appointment of Bob Lechleider, M.D., as Chief Medical Officer.

Persephone Biosciences Inc. today announced the launch of its Food as Medicine clinical study, AMBROSIA (NCT06091813).

Vaxcyte, Inc. (Nasdaq: PCVX) announced today that the U.S. Food and Drug Administration (FDA) has cleared the Company’s adult Investigational New Drug (IND) application for VAX-31, a 31-valent pneumococcal conjugate vaccine (PCV) candidate designed to prevent invasive pneumococcal disease (IPD).

Biological Dynamics, Inc., a leader in exosome-isolation technology for early disease detection, announced a newly published study in Nature’s Communications Medicine titled “Development of a Blood-Based EV Classifier for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma.”

North America’s largest pure-play distributor of scientific products, Thomas Scientific, has completed the acquisition of Lenexa, KS based forensics product provider Arrowhead Forensics.

ImmunoScape, a biotechnology company focused on next-generation immunotherapies, published new peer-reviewed research that demonstrates the use of machine learning to predict the virus specificity of human T-cells.

Phizzle, the leader in software used to automate data capture in biopharma applications,

Rise Therapeutics, a biotechnology company engaged in developing novel oral immunotherapeutics, today announced that the U.S. Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application to proceed with a rheumatoid arthritis Phase 1 clinical trial for its program candidate, R-2487.